I’m not anti-vaccine,” the independent candidate told Maher. “I’m called that because it’s a way of silencing me” ...
Three Motley Fool contributors think they can help out on that front. Here's why they picked AbbVie ( ABBV -4.58%), Eli Lilly ...
Pfizer Inc. won U.S. approval for its first gene therapy, expanding into a promising field of medicine that has proved to be ...
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants ...
Michele Catinella, a Nurse Practitioner at the John Knox Village Continuing Care Retirement Community receives a ...
We expect the company to post revenue of $13.8 billion and earnings of $0.50 on a per share and adjusted basis.
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene ...
With its lawsuit filed against Pfizer and BioNTech, the British multinational biopharma has joined the high-profile patent ...
Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech ...
The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the ...
Kaiser Permanente Entity Reports Breach Of Data For 13 Million: Kaiser Permanente, the Oakland-based health care conglomerate, is warning millions of customers that one of its divisions may have ...
Also, Maine's high court lets stand a mandate that EMS workers must be vaccinated against Covid. Reuters: GlaxoSmithKline Sues Pfizer And BioNTech Over Covid-19 Vaccine Technology GlaxoSmithKline sued ...